摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-4-oxothiazolidine | 107005-70-9

中文名称
——
中文别名
——
英文名称
2-methyl-4-oxothiazolidine
英文别名
2-methyl-4-thiazolidinone;2-methyl-thiazolidin-4-one;2-Methyl-thiazolidin-4-on;Methyl-4-thiazolidinone;2-methyl-1,3-thiazolidin-4-one
2-methyl-4-oxothiazolidine化学式
CAS
107005-70-9
化学式
C4H7NOS
mdl
MFCD19217103
分子量
117.172
InChiKey
PHMAYIMFUPPZRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    254 °C (decomp)(Solv: acetic acid (64-19-7))
  • 沸点:
    326.4±35.0 °C(Predicted)
  • 密度:
    1.163±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-methyl-4-oxothiazolidine邻氨基苯甲酸三氯氧磷 作用下, 反应 2.0h, 以50%的产率得到1-Methyl-3H-thiazolo[4,3-b]quinazolin-9-one
    参考文献:
    名称:
    Dunn, Allan D.; Norrie, Robert, Zeitschrift fur Chemie, 1990, vol. 30, # 8, p. 288 - 289
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Ishidate; Hashimoto, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1956, vol. 76, p. 73,76
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related
    申请人:Hoechst-Roussel Pharmaceuticals Incorporated
    公开号:US05229388A1
    公开(公告)日:1993-07-20
    There are disclosed compounds of the formula, ##STR1## where n is 0, 1 or 2; A is ##STR2## where X in each occurrence is independently hydrogen, halogen, loweralkyl, hydroxy, nitro, loweralkoxy, amino, cyano, trifluoromethyl or methylthio; Y in each occurrence is independently hydrogen, halogen, loweralkyl, hydroxy, nitro, loweralkoxy, amino, cyano, trifluoromethyl or methylthio; m is 1 or 2; k is 1 or 2; R.sub.1 and R.sub.2 are independently hydrogen, loweralkyl, ##STR3## or aryl except that when R.sub.1 is ##STR4## or aryl, R.sub.2 is hydrogen, or alternatively R.sub.1 +R.sub.2 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, indan or piperidine ring; R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl, or alternatively R.sub.3 +R.sub.4 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, pyrrolidine or piperidine ring, the term aryl signifying an unsubstituted phenyl group or a phenyl group substituted with 1, 2 or 3 substituents each of which being independently loweralkyl, loweralkoxy, hydroxy, halogen, loweralkylthio, cyano, amino or trifluoromethyl, which are useful as antipsychotic, analgesic, anticonvulsant and anxiolytic agents.
    公式中披露了化合物,其中n为0、1或2;A为其中X在每次出现时独立地为氢、卤素、较低烷基、羟基、硝基、较低烷氧基、氨基、氰基、三氟甲基或甲硫基;Y在每次出现时独立地为氢、卤素、较低烷基、羟基、硝基、较低烷氧基、氨基、氰基、三氟甲基或甲硫基;m为1或2;k为1或2;R.sub.1和R.sub.2独立地为氢、较低烷基、或芳基,但当R.sub.1为或芳基时,R.sub.2为氢,或者R.sub.1 +R.sub.2与它们附着的碳原子一起形成环戊烷、环己烷、环庚烷、吡喃、硫代吡喃、茚或哌啶环;R.sub.3和R.sub.4独立地为氢或较低烷基,或者R.sub.3 +R.sub.4与它们附着的碳原子一起形成环戊烷、环己烷、环庚烷、吡喃、硫代吡喃、吡咯烷或哌啶环,术语芳基表示未取代的苯基或一个苯基,其上取代基为1、2或3个,每个取代基独立地为较低烷基、较低烷氧基、羟基、卤素、较低烷硫基、氰基、氨基或三氟甲基,这些化合物可用作抗精神病、镇痛、抗癫痫和抗焦虑药物。
  • 3-[4-(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinone compounds
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04933453A1
    公开(公告)日:1990-06-12
    3-[4-1-substituted-4-piperazinyl)butyl]-4-thiazolidinone compounds which are useful as antipsychotic, analgesic, anticonvulsant and anxiolytic agents.
    3-[4-(1-取代-4-哌嗪基)丁基]-4-噻唑烷酮化合物可用作抗精神病药、镇痛药、抗抽搐药和抗焦虑药。
  • Structure−Activity Relationships of a Series of Novel (Piperazinylbutyl)thiazolidinone Antipsychotic Agents Related to 3-[4-[4-(6-Fluorobenzo[<i>b</i>]thien-3-yl)-1-piperazinyl]butyl]-2,5,5-trimethyl-4- thiazolidinone Maleate
    作者:Nicholas J. Hrib、John G. Jurcak、Deborah E. Bregna、Kendra L. Burgher、Harold B. Hartman、Sharon Kafka、Lisa L. Kerman、Sam Kongsamut、Joachim E. Roehr、Mark R. Szewczak、Ann T. Woods-Kettelberger、Roy Corbett
    DOI:10.1021/jm960268u
    日期:1996.1.1
    butyl thiazolidinones structurally related to this compound were prepared and evaluated in vitro for dopamine D2 and serotonin 5HT2 and 5HT1A receptor affinity. The compounds were examined in vivo in animal models of potential antipsychotic activity and screened in models predictive of extrapyramidal side effect (EPS) liability. The synthesis of these compounds, details of their structure-activity relationships
    HP-236(3- [4- [4-(6-氟苯并[b]噻吩-3-基)-1-哌嗪基]丁基] -2,5,5-三甲基-4-噻唑烷酮马来酸酯; P-9236) (54)显示了潜在的非典型抗精神病药活性的药理学特征。制备了与该化合物结构相关的一系列哌嗪基丁基丁基噻唑烷酮,并在体外评估了多巴胺D2和5-羟色胺5HT2和5HT1A受体的亲和力。在具有潜在抗精神病活性的动物模型中对化合物进行了体内检查,并在预测锥体束外副作用(EPS)责任的模型中进行了筛选。描述了这些化合物的合成,其结构-活性关系的详细信息以及新的先导化合物50的发现,以及化合物50和54的分布图的进一步发展。
  • 4-(3-(4-oxothiazolidinyl)butynylamines
    申请人:Hoechst-Roussel Pharmaceuticals Incorporated
    公开号:US05034392A1
    公开(公告)日:1991-07-23
    This invention relates to compounds of the formula ##STR1## where R.sub.1 and R.sub.2 are independently hydrogen or loweralkyl or R.sub.1 and R.sub.2 taken together with the carbon atom to which they are attached form a spiro-fused cycloalkane of 5 to 8 carbons; R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl or R.sub.3 and R.sub.4 taken together with the carbon atom to which they are attached form a spiro-fused cycloalkane of 5 to 8 carbons; R.sub.5 and R.sub.6 taken together with the nitrogen atom to which they are attached are ##STR2## where X in each occurrence is independently hydrogen, halogen, loweralkyl, hydroxy, nitro, amino, cyano, trifluoromethyl or methoxy; and m is 0, 1 or 2; the pharmaceutically acceptable acid addition salts thereof and where applicable the optical and geometrical isomers and racemic mixtures thereof. The compounds of this invention are useful as analgesic and antihypertensive agents.
    这项发明涉及以下公式的化合物##STR1##其中R.sub.1和R.sub.2分别独立地是氢或较低的烷基,或R.sub.1和R.sub.2与它们连接的碳原子一起形成含有5到8个碳原子的螺环融合环烷;R.sub.3和R.sub.4分别独立地是氢或较低的烷基,或R.sub.3和R.sub.4与它们连接的碳原子一起形成含有5到8个碳原子的螺环融合环烷;R.sub.5和R.sub.6与它们连接的氮原子一起是##STR2##其中每次出现的X独立地是氢、卤素、较低的烷基、羟基、硝基、氨基、氰基、三氟甲基或甲氧基;m为0、1或2;其药学上可接受的酸盐以及适用的光学和几何异构体和其外消旋混合物。本发明的化合物可用作镇痛和降压剂。
  • Organophosphorus, compounds and insecticidal, miticidal, nematicidal or
    申请人:Ishihara Sangyo Kaisha Ltd.
    公开号:US04783451A1
    公开(公告)日:1988-11-08
    An organophosphorus compound having the formula: ##STR1## wherein X is ##STR2## Z is an oxygen atom or a sulfur atom, and each of R.sub.1 and R.sub.2 is an alkyl group which may be substituted by halogen, alkoxy or alkylthio. The compound is useful as an insecticide, miticide, nematicide or soil pesticide.
    一种有机磷化合物,化学式为:##STR1## 其中X为##STR2##,Z为氧原子或硫原子,R.sub.1和R.sub.2均为烷基,可被卤素,烷氧基或烷硫基取代。该化合物可用作杀虫剂、杀螨剂、线虫杀剂或土壤杀虫剂。
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英